I did not attach a screenshot for receivables. Here is one from the annual report.
Total Receivables were 592Cr on march 2022, 658Cr on march 2023
The company allocated 93Cr provision for loss from receivables in 2022 and 132 Cr in 2023
Posts tagged Value Pickr
CMS Info Systems Ltd (29-04-2024)
Investing Basics – Feel free to ask the most basic questions (29-04-2024)
@Girish_Kolari @mohit_sharma IndAS 116 is only for long term lease. Short term lease get expensed out in P&L
Action construction equipment ltd (29-04-2024)
Even by Vahan regs, FY25 April is highest till date they have done in an April month of any year.
Gufic BioSciences Ltd (29-04-2024)
Hi All,
In the Q3 Concal FY24, the Arisia center was discussed extensively where they would offer anti aging treatments (368 products/services) for all parts of the body including vaginal rejuvenation and also vaginal tightening and mentioned that the costing is from INR 5,000 to INR 15,00,000. They have mentioned that they are close to break even + 10% and would mimic this model at a national level. Would large number of people pay such a price for this segment to be significant for the company? The company mentions the number of footfalls are increasing atleast 10% month on month but what would be scale they can hit.
VPers, please share your thoughts.
Disclosure : only tracking, not invested
PNB Housing Fin – Fast Growing HFC (29-04-2024)
Q4FY24 Con-call Notes:
Loan Book and Disbursements
Q4’24 & FY24 performance
• Company continues its stated objective of growing its retail book and running down its corporate book.
• As of 31st March 2024, retail loans form 97% of loan book (balance 3% being corporate).
• Recent performance w.r.t. disbursement and loans is as below: –
Disbursements(value & growth) | ||||
---|---|---|---|---|
Q4 ’24 | QoQ (seq.) growth | FY 24 | YoY Growth | |
Retail Disbursements (A) | 5541 Cr | 35% | 17483 Cr | 18.50% |
Corpoarte Disbursements (B) | 33 Cr | 1% | 100 Cr | -54% |
Total (A+B) | 5574 Cr | 35% | 17853 Cr | 17.5% |
Loan Book (value & growth) | |||
---|---|---|---|
As on 31st March 2024 | QoQ (seq.) growth | YoY Growth | |
Retail Loan Book (A) | 63306 Cr | 5% | 14.1% |
Corpoarte Loan book (B) | 2052 Cr | -7% | -46% |
Total (A+B) | 65358 Cr | 5% | 10.3% |
• Retail segment now consist of 3 verticals:
(a) Prime: Currently 97% of retail loan book; grew at 4% QoQ; Avg ticket size = 35Lakhs; targets 9-10% yield
(b) Affordable: Currently 3% of retail loan book; grew at 56% QoQ; contributed to 12% of total retail disbursements in Q4’24; Avg ticket size = 15Lakhs; targets 11-13% yield, 1/3rd customers new to credit.
(c) Emerging: Business to start from Q1’25, focus on high yielding (10-11%) part of Prime business in Tier 2/Tier 3 cities
Guidance on growth
• Around 17% growth projected on retail loan book for FY 25.
• One of the key factors driving growth will be the additional 100 branches opened between Dec ‘23-Mar ’24 (60 in affordable vertical, 22 in emerging & 18 in prime).
• As per management the FY24 business was practically from 200 branches, while FY 25 will be from 300 branches.
• Each of these verticals will have there own credit, sales & collection teams.
• As to why can’t growth be higher (esp. since currently leverage is quite low), management says it wants to maintain the asset quality and NIM levels.
• 40-45% of retail business in FY25 is likely to be from affordable & emerging verticals (which are relatively higher yield)
• Plan to start re-growing corporate lending business from H2’FY25 (the plan is to keep it in single digits as a % of overall loan book)
Profitability related
PAT
• Q4’24 PAT is 439 Cr vs Q3’24 PAT of 338 cores – QoQ sequential jump of 30%
• For full FY24 PAT is 1,508 Cr vs FY23 PAT of 1,046 Cr (these are ex. one off nos.) – jump of 44%.
ROA, ROE & NIM guidance
• FY24 ROA = 2.2% vs FY23 ROA = 1.6%
• ROA guidance for FY25 is 2.1% plus.
• FY24 ROE = 10.9%. Management expects ROE to go back to “reasonable” levels in next 3 years as more and more leverage is added (Note: while they didn’t say what is meant by reasonable level, if one were to guess it probably means 15% to higher teens kind of level)
• NIM guidance for FY25 = 3.5%
Yields and cost of borrowing
• Q4’24 yield = 10.08% vs Q3’24 yield = 10.19%. This drop in yield is due to depletion in Prime loan book, caused by bank transfers etc. due to heavy competition.
• Management expects to improve the yield in FY25 (compared to Q4’24) due to increased focus on Affordable & Emerging verticals.
• The yield from Affordable segments is expected to go up 100 bps from 11.5% to 12.5% in FY25.
• Average Cost of borrowing for FY24 was 8.01%. The management expects it to come down somewhat as they now have been upgraded to AA+ by India Ratings, ICRA & CARE.
Impact of additional branches on Opex
• As per mgmt., there will be “some impact” of opening 100 additional branches, but the higher yields justify it. Opex to ATA was 0.93% in FY24, which might move to 0.95% to 1% in FY25.
• An average branch in the Affordable vertical breaks even in around 8 months.
Asset quality related
• The GNPA trend over the last 12 months has been as follows: –
GNPA% | |||
---|---|---|---|
31-Mar-24 | 31-Dec-23 | 31-Mar-23 | |
Retail | 1.45% | 1.67% | 2.57% |
Corpoarte | 3.31% | 3.35% | 22.25% |
Overall | 1.50% | 1.73% | 3.8% |
• A corporate account with a current outstanding loan value of 126 cores moved into stage 2 in Q4’24. The management currently believes that it will remain there or come back to stage 1.
• Management was able to write back Rs.99 crores from the write-off pool in FY 24 (out of which 49 crores came in Q4’24 – this is why credit cost was just 0.04% in this quarter).
• The current write-off pool is 1700 crores (retail) and 500 crores (corporate). As an approximate guidance, management expects 50 crores of write back every quarter for FY25.
• Credit cost guidance for FY 25 is 0.30%. This doesn’t include any write backs that might happen.
(Disclosure: invested with a small tracking position)
Hitesh portfolio (29-04-2024)
While trying to get into cash the preferred exits would be in lowest conviction or lowest performing stocks. The short term momentum trades would obviously be the first ones to go under the hammer.
Exiting longer term bets would be in case of extremely extended unsustainable moves. ( this is easier said than done.)
All these are planned moves as of now, but many a times we have to improvise strategies (including getting into cash) as we move ahead. Getting some dry powder is an aspirational move. I haven’t done this kind of thing since a long time now, so it would be a slight psychological adjustment on my part.
@ank007 I don’t track Jupiter wagons.
Advanced Enzyme Technologies Ltd – The Enzyme company (29-04-2024)
Have they completely sold off or it has gone below 1% and hence not shown?
Tata Consumer Products Limited (TATACONSUM) (29-04-2024)
Tata consumer is consolidating from January 2024. Already below 10 week EMA and , 30 week EMA is getting flatter. Last both quarters, sales have been low and earnings have been negative. So seems to be going into consolidation Stage 3 . I amd having a small position, which i will be getting rid of soon.
IDFC First Bank Limited (29-04-2024)
IDFC First Bank: Q4 Misses Estimate; Outlook On FY25 Margins, Guidance | MD & CEO V Vaidyanathan
VV’s vision about the future of IDFC First Bank.